C. L. Heifetz

发表

Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.

S. Hagen, J. Domagala, J. Sánchez, 1988, Journal of medicinal chemistry.

Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids.

S. Hagen, J. Domagala, J. Johnson, 1991, Journal of medicinal chemistry.

Comparative Urine Concentrations of Sulfacytine, A New Sulfonamide

R. Buchanan, J. Goulet, Thomas C. Smith, 1977 .

Disc-agar diffusion microbiological assay procedure for determining serum and urine levels of sulfacytine and other sulfonamides.

C. L. Heifetz, J. A. Chodubski, M. DeCarlo, 1971, Applied microbiology.

CI-867, a new broad-spectrum semisynthetic penicillin.

T. Haskell, C. L. Heifetz, D. Dejohn, 1979, The Journal of antibiotics.

1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.

J. Domagala, C. L. Heifetz, M. P. Hutt, 1988, Journal of medicinal chemistry.

Synthesis and biological activity of a new semisynthetic cephalosporin, CN-92,982.

P. W. Woo, T. Haskell, J. Sánchez, 1980, The Journal of antibiotics.

New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.

J. Domagala, J M Domagala, L D Hanna, 1986, Journal of medicinal chemistry.

A novel rapid throughput phototolerance screen in mice.

M. Shapiro, C. L. Heifetz, J. Dever, 1996, Journal of pharmacological and toxicological methods.

In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria

M. Cohen, J. Domagala, C. L. Heifetz, 1985, Antimicrobial Agents and Chemotherapy.

5″-Amino-5″-Deoxybutirosin, a Semisynthetic Analogue of Butirosin A: Antibacterial Activity In Vitro and in Mice

C. L. Heifetz, I. A. Pearson, J. C. Sesnie, 1976, Antimicrobial Agents and Chemotherapy.

In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria.

M. Cohen, S. Yoder, M. Huband, 1991, Diagnostic microbiology and infectious disease.

In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391.

M. Cohen, S. Yoder, M. Huband, 1991, Diagnostic microbiology and infectious disease.

Comparison of microdilution and agar dilution procedures for testing antibiotic susceptibility of Neisseria gonorrhoeae

M. Shapiro, C. L. Heifetz, J. C. Sesnie, 1984, Journal of clinical microbiology.

Phenazopyridine-Sulfonamide Combination Antibacterial Therapy in Mice

C. L. Heifetz, M. W. Fisher, 1973, Antimicrobial Agents and Chemotherapy.

New 8-(trifluoromethyl)-substituted quinolones. The benefits of the 8-fluoro group with reduced phototoxic risk.

S. Hagen, J. Domagala, M. Shapiro, 1992, Journal of medicinal chemistry.

Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonas activity.

J. Domagala, J. Sánchez, C. L. Heifetz, 1992, Journal of medicinal chemistry.

Butirosin, a New Aminoglycosidic Antibiotic Complex: Antibacterial Activity In Vitro and in Mice

C. L. Heifetz, J. A. Chodubski, M. DeCarlo, 1972, Antimicrobial Agents and Chemotherapy.

Butirosin Compared with Gentamicin In Vitro and In Vivo

C. L. Heifetz, I. A. Pearson, J. A. Chodubski, 1974, Antimicrobial Agents and Chemotherapy.

Disc-Agar Diffusion Microbiological Assay Procedure for Determining Serum and Urine Levels of Sulfacytine and Other Sulfonamides

C. L. Heifetz, M. Fisher, J. A. Chodubski, 1971 .

In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models.

M. Cohen, S. Yoder, S. Wold, 1994, Diagnostic microbiology and infectious disease.

In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and beta-lactamase stability.

M. Cohen, M. Huband, M. Shapiro, 1994, Diagnostic microbiology and infectious disease.

Bacterial and mammalian cell mutagenesis, sister-chromatid exchange, and mouse lung adenoma bioassay with the antineoplastic acridine derivative amsacrine.

G. Stoner, E. McGuire, F. A. de la Iglesia, 1984, Journal of toxicology and environmental health.

In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent

M. Cohen, S. Yoder, J. Domagala, 1991, Antimicrobial Agents and Chemotherapy.

1-Substituted 7-(3-((Ethylamino)methyl)-1-pyrrolidinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acids. New Quantitative Structure-Activity Relationships at N1 for the Quinolone Antibacterials.

J. Domagala, C. L. Heifetz, M. P. Hutt, 1988 .

1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.

J. Domagala, C. L. Heifetz, J. B. Nichols, 1986, Journal of medicinal chemistry.

7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.

S. Hagen, J. Domagala, J. Sánchez, 1988, Journal of medicinal chemistry.

Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic.

M. Cohen, A. Sugar, C. L. Heifetz, 1986, Archives of ophthalmology.